文献速递皮肤肿瘤

淋巴血管侵犯是皮肤鳞状细胞癌转移和疾病特异性死亡的独立预测因素:多中心回顾性研究

Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: A multicenter retrospective study.
PubMed 文献 · J Am Acad Dermatol · 2025-04-17

LVI+肿瘤发生主要不良结局(淋巴结转移、途中转移、远处转移和疾病特异性死亡)的3年累积发生率显著高于LVI-肿瘤(33.5% vs 3.2%,P < .001),调整后LVI+肿瘤发生主要不良结局的风险增加82%(亚分布风险比=1.82,P = .002)。LVI是CSCC转移和疾病特异性死亡的独立预测因素,在低分期和高分期BWH肿瘤中均如此。

要点

  • LVI+皮肤鳞状细胞癌患者3年主要不良结局累积发生率为33.5%,显著高于LVI-患者的3.2%。
  • 调整分析显示LVI+肿瘤发生主要不良结局的风险增加82%(亚分布风险比=1.82,P = .002)。
  • LVI+低分期BWH肿瘤(T1或T2a)3年主要不良结局累积发生率为20.7%,高于LVI-低分期肿瘤的1.61%。

核心结论

  • 皮肤鳞状细胞癌中淋巴血管侵犯的存在是高危特征,是低和高BWH分期肿瘤转移和疾病特异性死亡的独立预测因素。

主要发现

  • 淋巴血管侵犯阳性肿瘤3年主要不良结局累积发生率为33.5%,淋巴血管侵犯阴性肿瘤为3.2%(总体累积发生率函数P < .001)。
  • 调整分析中,淋巴血管侵犯阳性肿瘤发生主要不良结局的亚分布风险比为1.82(P = .002)。
  • 淋巴血管侵犯阳性低分期BWH肿瘤(T1或T2a)3年主要不良结局累积发生率为20.7%,淋巴血管侵犯阴性低分期肿瘤为1.61%(总体累积发生率函数P < .001)。

关键数值与推荐

  • 主要不良结局定义为淋巴结转移、途中转移、远处转移和疾病特异性死亡。
  • 淋巴血管侵犯阳性肿瘤较阴性肿瘤发生主要不良结局的率增加82%(亚分布风险比=1.82,P = .002)。
  • 淋巴血管侵犯阳性低分期BWH肿瘤(T1或T2a)3年主要不良结局累积发生率为20.7%,阴性低分期肿瘤为1.61%(P < .001)。

临床怎么用

  • 对皮肤鳞状细胞癌应评估淋巴血管侵犯状态,因其为独立预测转移和疾病特异性死亡的高危特征。
  • 淋巴血管侵犯阳性低分期BWH肿瘤(T1或T2a)仍具有较高的主要不良结局风险,需加强监测和管理。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymphovascular invasion (LVI) is regarded as a high-risk feature of cutaneous squamous cell carcinoma (CSCC) but is currently absent from CSCC staging systems. OBJECTIVE: To assess whether LVI serves as an independent predictor of major poor outcomes in CSCC. METHODS: Twelve centers contributed to a multinational CSCC database. Clinical and pathologic risk factors, treatment, and patient outcomes were retrospectively collected. CSCCs were stratified based on LVI status. Tumors that developed major poor outcomes defined as nodal metastasis, in-transit metastasis, distant metastasis, and disease-specific death were identified. RESULTS: A total of 23,166 CSCCs were identified, 179 were LVI+ tumors (0.8%). LVI+ tumors had a higher cumulative incidence of major poor outcomes than those without LVI (33.5% vs 3.2% at 3 years; overall cumulative incidence function P < .001). In an adjusted analysis, LVI+ tumors had an 82% increase in the rate of developing major poor outcomes when compared to LVI- tumors (subdistribution hazard ratio = 1.82; P = .002). Notably, LVI+ low-stage Brigham and Women's Hospital (BWH) tumors (T1 or T2a) had a greater cumulative incidence of major poor outcomes compared to LVI- BWH low-stage tumors (20.7% vs 1.61% at 3 years, overall cumulative incidence function P < .001). LIMITATIONS: Retrospective study design. CONCLUSION: The presence of LVI in CSCC is a high-risk feature that is an independent predictor of metastasis and disease-specific death in both low and high BWH stage tumors.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Hirotsu KE, Aasi SZ, Samson KK, et al. Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: A multicenter retrospective study. J Am Acad Dermatol. 2025. PMID: 40253009. doi:10.1016/j.jaad.2025.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。